BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
9.33
-0.23 (-2.41%)
At close: Mar 27, 2026, 4:00 PM EDT
9.39
+0.06 (0.64%)
After-hours: Mar 27, 2026, 7:55 PM EDT
BioCryst Pharmaceuticals Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$20.82
Upside
+123.15%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +39.34% | Jan 30, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +242.98% | Dec 15, 2025 |
| Citizens | Citizens | Buy Maintains $27 → $25 | Buy | Maintains | $27 → $25 | +167.95% | Nov 5, 2025 |
| Barclays | Barclays | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | -3.54% | Nov 4, 2025 |
| Needham | Needham | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +92.93% | Nov 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +221.54% | Oct 15, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $24 → $26 | Buy | Maintains | $24 → $26 | +178.67% | Oct 15, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $17 → $27 | Buy | Maintains | $17 → $27 | +189.39% | Oct 15, 2025 |
| Needham | Needham | Strong Buy Maintains $17 → $20 | Strong Buy | Maintains | $17 → $20 | +114.36% | Oct 15, 2025 |
| Needham | Needham | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +82.21% | Aug 4, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +60.77% | Jul 1, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $13 | Buy | Reiterates | $13 | +39.34% | Jun 30, 2025 |
| Wedbush | Wedbush | Buy Maintains $16 → $18 | Buy | Maintains | $16 → $18 | +92.93% | Jun 30, 2025 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +82.21% | Jun 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +82.21% | Jun 25, 2025 |
| Barclays | Barclays | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | +17.90% | May 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.